Sinovac Biotech

September 09, 2020

Covid vaccine developers face nervous wait

More details on an adverse event in a trial of Astrazeneca's AZD1222 will be needed to assess the fallout for other vaccine developers.

June 04, 2020

Have Glaxo and Sanofi been snubbed by Project Warp Speed?

May 19, 2020

Moderna reminds the markets of biotech’s dual purpose

On the back of coronavirus mania, Moderna, a $30bn company heavily funded by the US government, taps investors for $1.3bn.

March 11, 2020

For a Covid-19 vaccine, WHO you gonna call?

March 09, 2020

Will sales of any Covid-19 vaccine echo swine and avian flu shots?

March 15, 2013

Therapeutic focus – Sinovac leads China’s hand, foot and mouth disease race

April 28, 2009

Pandemic threat prompts surge of speculative investments